⌘K

Login Start Free

Home/Filings/4/0001140361-25-015712

4//SEC Filing

Ye Weiguo 4

Accession 0001140361-25-015712

CIK 0001124105other

View on SEC.gov Company Profile

Filed

Apr 24, 8:00 PM ET

Accepted

Apr 25, 4:01 PM ET

Size

13.4 KB

Accession

0001140361-25-015712

Insider Transaction Report

Form 4

Period: 2025-03-24

GYRE THERAPEUTICS, INC.GYRE

Chief Operating Officer

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2025-03-26−200,000→ 1,165,115 total
Exercise: $0.75Exp: 2030-10-31→ Common Stock (200,000 underlying)
Exercise/Conversion
Common Stock
2025-03-24$0.75/sh+300,000$225,000→ 300,000 total
Exercise/Conversion
Common Stock
2025-03-26$0.75/sh+200,000$150,000→ 500,000 total
Exercise/Conversion
Common Stock
2025-03-27$0.75/sh+150,000$112,500→ 650,000 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-03-24−300,000→ 1,365,115 total
Exercise: $0.75Exp: 2030-10-31→ Common Stock (300,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-03-27−150,000→ 1,015,115 total
Exercise: $0.75Exp: 2030-10-31→ Common Stock (150,000 underlying)

Footnotes (1)

[F1]These options are vested in full.

Documents

1 file

4
form4.xmlPrimary
FORM 4

Issuer

GYRE THERAPEUTICS, INC.

CIK 0001124105

Entity typeother

Related Parties

1

filerCIK 0001985496

Filing Metadata

Form type: 4
Filed: Apr 24, 8:00 PM ET
Accepted: Apr 25, 4:01 PM ET
Size: 13.4 KB

View on SEC.gov